A Novel Artificial Intelligence-powered Tool for Precise Risk Stratification of Prostate Cancer Progression in Patients with Clinical Intermediate Risk
1 Department of Urology and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: sujit.nair@mountsinai.org.
2 PathomIQ Inc, Cupertino, CA, USA.
3 Department of Urology and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
4 Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
5 PathomIQ Inc, Cupertino, CA, USA; Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
6 Department of Urology and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: dimple.chakravarty@mountsinai.org.
7 Department of Urology and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: ash.tewari@mountsinai.org.